P8A.SI Cordlife Group Ltd (SES) up 10.77% after hours 25 Feb 2026: volume signals interest
P8A.SI stock climbed 10.77% in after-hours trade on 25 Feb 2026, closing at S$0.144 on the Singapore Exchange (SES) after an intraday move from S$0.130. The jump followed heavier-than-average activity for this micro-cap healthcare name, and it came with no recorded regular-session volume today against an average daily volume of 17,498 shares. Investors will watch liquidity, valuation and recent earnings trends as Cordlife Group Limited (P8A.SI) shows oversold technicals while trading well below its 52-week high of S$0.33.
P8A.SI stock price action and volume signals
Cordlife Group Limited (P8A.SI) closed after hours at S$0.144, up S$0.014 or 10.77% from the previous close of S$0.130 on the SES. The stock recorded no regular-session volume today but the reported move and a relVolume of 0.63 suggest higher interest toward the close and in the after-hours window. Year range is S$0.127 to S$0.330, and the 50-day average is S$0.1412, indicating the move pushes the price slightly above near-term average but well below the 200-day average of S$0.1963.
P8A.SI stock fundamentals and valuation metrics
Cordlife shows a market cap of S$33,320,007.00 and shares outstanding of 256,307,744. Key ratios: EPS -0.05, PE -2.60, P/S 1.16, P/B 0.30, and current ratio 3.13, which highlight a conservative balance sheet with low leverage (debt/equity 0.01) but negative profitability (net margin -29.53%). Book value per share is S$0.4373 and cash per share is S$0.2032, leaving tangible cushion for a company focused on cord blood banking and diagnostics across Asia.
P8A.SI stock technicals and trading indicators
Technicals show oversold conditions: RSI 29.70 and CCI -198.80, while ADX at 34.34 points to a strong trend. Bollinger bands sit at 0.13–0.16 and MACD components are effectively flat, suggesting price momentum may need confirmation. Short-term traders will note low daily liquidity and an average volume of 17,498 shares, increasing trade risk despite the after-hours uptick.
Meyka AI rates P8A.SI with a score out of 100 and model forecast
Meyka AI rates P8A.SI with a score out of 100: 62.11 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects monthly S$0.150, quarterly S$0.230, and yearly S$0.3042 targets versus the current price of S$0.144, implying a 12-month upside of 111.29%. Forecasts are model-based projections and not guarantees.
Catalysts, sector context and risks for P8A.SI stock
Cordlife operates in the Healthcare sector on the SES, where peers showed 3-month gains of 8.21%; sector tailwinds for diagnostics and private banking services could help revenue growth. Near-term catalysts include contract wins in regional markets, new diagnostics offerings and earnings updates. Key risks: persistent negative EPS, long receivables cycle (DSO 255.59 days), modest liquidity at the trading level, and pricing below the 200-day average.
Price targets and analyst signals for P8A.SI stock
Market-derived targets and model outputs point to short-term targets of S$0.15 and a 3-month technical resistance at S$0.23 while the 12-month model target is S$0.3042. A recent company rating (23 Feb 2026) showed a B- and a Sell recommendation from a third-party aggregator, highlighting mixed sentiment. For active traders, a stop-loss below the S$0.127 year low and position sizing to manage volatility are prudent.
Final Thoughts
P8A.SI stock posted a notable after-hours move on 25 Feb 2026, closing at S$0.144 after gaining 10.77% from S$0.130. The advance came with limited on-exchange volume for the regular session, so traders should treat the move as a liquidity-driven event until higher traded volume confirms momentum. Fundamental metrics show low leverage, a P/B of 0.30, and cash per share S$0.2032, but profitability remains negative with EPS -0.05 and net margin -29.53%. Meyka AI’s models project a 12-month target of S$0.3042, implying an upside of 111.29% versus the current price; we reiterate forecasts are model-based projections and not guarantees. Given the B grade and HOLD suggestion from Meyka AI, institutional investors may wait for clearer volume confirmation and improved earnings cadence, while short-term traders can use tight risk controls and watch for updates on contracts or diagnostics rollouts that could validate higher price targets. For a full company disclosure and announcements, check Cordlife’s investor page and SGX filings.
FAQs
What drove the P8A.SI stock move after hours on 25 Feb 2026?
The after-hours rise to S$0.144 (+10.77%) reflected increased trading interest around close and speculative buying; there was no single public earnings release. Low regular-session volume means the move likely reflects liquidity flows and short-term positioning rather than confirmed fundamental news
What is Meyka AI’s view and grade for P8A.SI stock?
Meyka AI rates P8A.SI with a score out of 100: 62.11, Grade B, Suggestion HOLD. The grade considers benchmark and sector comparisons, financial growth, key metrics, forecasts and analyst signals
What price targets and upside does the P8A.SI stock forecast show?
Meyka AI’s forecast model projects monthly S$0.150, quarterly S$0.230 and yearly S$0.3042 versus the current S$0.144, implying a 12-month upside of about 111.29%. Forecasts are model-based projections and not guarantees
What are the main risks for P8A.SI stock investors?
Key risks include negative EPS (−0.05), long receivables (DSO 255.59 days), thin regular-session liquidity (avg vol 17,498), and a share price below the 200-day average. These raise execution and earnings risks for investors
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.